ATE317386T1 - Dihydroindol- und tetrahydrochinolinderivate - Google Patents

Dihydroindol- und tetrahydrochinolinderivate

Info

Publication number
ATE317386T1
ATE317386T1 AT01271362T AT01271362T ATE317386T1 AT E317386 T1 ATE317386 T1 AT E317386T1 AT 01271362 T AT01271362 T AT 01271362T AT 01271362 T AT01271362 T AT 01271362T AT E317386 T1 ATE317386 T1 AT E317386T1
Authority
AT
Austria
Prior art keywords
tetrahydrocinoline
dihydroindole
derivatives
tetrahydrocinoline derivatives
Prior art date
Application number
AT01271362T
Other languages
German (de)
English (en)
Inventor
Johannes Aebi
Jean Ackermann
Alexander Chucholowski
Henrietta Dehmlow
Olivier Morand
Sabine Wallbaum
Thomas Weller
Narendra Panday
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE317386T1 publication Critical patent/ATE317386T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Oncology (AREA)
  • Vascular Medicine (AREA)
  • Communicable Diseases (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Quinoline Compounds (AREA)
AT01271362T 2000-12-21 2001-12-12 Dihydroindol- und tetrahydrochinolinderivate ATE317386T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00128063 2000-12-21

Publications (1)

Publication Number Publication Date
ATE317386T1 true ATE317386T1 (de) 2006-02-15

Family

ID=8170751

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01271362T ATE317386T1 (de) 2000-12-21 2001-12-12 Dihydroindol- und tetrahydrochinolinderivate

Country Status (15)

Country Link
US (2) US6706751B2 (enExample)
EP (1) EP1358162B1 (enExample)
JP (1) JP4068459B2 (enExample)
KR (1) KR100530408B1 (enExample)
CN (1) CN1208322C (enExample)
AR (1) AR035408A1 (enExample)
AT (1) ATE317386T1 (enExample)
AU (2) AU1917602A (enExample)
BR (1) BR0116263A (enExample)
CA (1) CA2431100C (enExample)
DE (1) DE60117096T2 (enExample)
ES (1) ES2257381T3 (enExample)
MX (1) MXPA03005395A (enExample)
WO (1) WO2002050041A1 (enExample)
ZA (1) ZA200304646B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR037647A1 (es) 2002-05-29 2004-12-01 Novartis Ag Derivados de diarilurea utiles para el tratamiento de enfermedades dependientes de la cinasa de proteina
DK1537078T3 (da) * 2002-08-29 2010-08-02 Merck Sharp & Dohme Indoler med anti-diabetisk aktivitet
JP4479656B2 (ja) * 2003-08-08 2010-06-09 宇部興産株式会社 アルキニル基置換縮合ヘテロ環化合物及びその製法並びにそれを使用する有機エレクトロルミネッセンス素子
TWI329102B (en) * 2006-08-15 2010-08-21 Nat Health Research Institutes Thiourea compounds and method for inhibiting hepatitis c virus infection
WO2008124300A1 (en) * 2007-04-10 2008-10-16 National Health Research Institutes Hepatitis c virus inhibitors
US7897764B2 (en) * 2007-06-08 2011-03-01 National Health Research Institutes Thiourea derivatives
TWI361808B (en) * 2008-01-08 2012-04-11 Nat Health Research Institutes Imidazolidinone and imidazolidinethione derivatives
US8198284B2 (en) * 2008-04-30 2012-06-12 National Health Research Institutes Treatment of neurodegenerative disorders with thiourea compounds

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3997542A (en) * 1975-06-23 1976-12-14 Sterling Drug Inc. 1-(Halogenated-acetyl)-1,2,3,4-tetrahydro-6-quinolinols and esters thereof
NZ227042A (en) 1987-11-27 1991-05-28 Banyu Pharma Co Ltd Substituted alkylamine derivatives and pharmaceutical compositions
US5288749A (en) 1991-12-20 1994-02-22 Abbott Laboratories Tertiary and secondary amines as alpha-2 antagonists and serotonin uptake inhibitors
TW438774B (en) 1993-07-14 2001-06-07 Hoffmann La Roche Pharmaceutical composition for lowering cholesterol containing phenalkylamines and certain novel phenalkylamines
US6313127B1 (en) 1996-02-02 2001-11-06 Zeneca Limited Heterocyclic compounds useful as pharmaceutical agents
DE19727117A1 (de) 1997-06-26 1999-01-07 Boehringer Ingelheim Pharma Phenylalkylderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
EP1283199A4 (en) 2000-05-16 2003-12-17 Takeda Chemical Industries Ltd MELANINE CONCENTRATING HORMONE ANTAGONISTS

Also Published As

Publication number Publication date
DE60117096D1 (de) 2006-04-20
CN1208322C (zh) 2005-06-29
CA2431100A1 (en) 2002-06-27
KR20030063453A (ko) 2003-07-28
CN1481366A (zh) 2004-03-10
US6706751B2 (en) 2004-03-16
MXPA03005395A (es) 2003-09-25
KR100530408B1 (ko) 2005-11-22
BR0116263A (pt) 2003-12-30
US20030004156A1 (en) 2003-01-02
DE60117096T2 (de) 2006-11-23
US20050020624A1 (en) 2005-01-27
ES2257381T3 (es) 2006-08-01
CA2431100C (en) 2009-03-24
EP1358162B1 (en) 2006-02-08
ZA200304646B (en) 2004-09-13
AU2002219176B2 (en) 2006-02-09
AU1917602A (en) 2002-07-01
EP1358162A1 (en) 2003-11-05
AR035408A1 (es) 2004-05-26
WO2002050041A1 (en) 2002-06-27
JP2004519441A (ja) 2004-07-02
US7102007B2 (en) 2006-09-05
JP4068459B2 (ja) 2008-03-26

Similar Documents

Publication Publication Date Title
IS6385A (is) Ný notkun og nýjar N-asabísýkló-amíð afleiður
DE50112013D1 (de) Deodorantien und antiperspirantien
DK1454907T3 (da) Quninazolin og pyridopyrmidin-derivativer
ATE540013T1 (de) Naphthalinderivate
NO20014096L (no) Fenyl- og pyridinylderivater
DK1292604T3 (da) 2-Aminocarbonyl-9H-purinderivater
AR028622A1 (es) Derivados de tropano utiles en terapia
IS6411A (is) Kaspasa tálmar og notkun þeirra
NO20012567D0 (no) Azepinoindolderivater, fremstilling og anvendelse derav
NO20021379D0 (no) Benzodiazepin-derivater, fremstilling og anvendelse derav
AR028343A1 (es) Derivados de pirrolidina y piperidina
ATE288437T1 (de) Tetrahydro-heterocycloazepinyl-pyrimidin-deriva e
DE60032898D1 (de) Arylthiazolidindion- und aryloxazolidinderivate
DE60139763D1 (de) Lanzen und -tieren
DK1280809T3 (da) Antitumorecteinascidinderivater
ATE298332T1 (de) Decahydro-isochinolinderivate
NO20023770L (no) Indol-3-ylderivater
NO20025510L (no) Dibenzoazulen-derivater samt anvendelse derav
ATE257148T1 (de) Propargyletherderivate
DE60107990D1 (de) Foliebehandlungsvorrichtung und Umwickelvorrichtung
DE60028486D1 (de) Videocoder und -decoder
ATE254598T1 (de) 4-hydroxybiphenylhydrazid-derivate
DK1322593T3 (da) O-substituerede-6-methyl-tramadol-derivater
ATE317386T1 (de) Dihydroindol- und tetrahydrochinolinderivate
PT1178981E (pt) 3-piridil-4-arilpirrois substituidos e metodos terapeuticos e profilacticos

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1358162

Country of ref document: EP

REN Ceased due to non-payment of the annual fee